- Home
- ADAM vs PRME Comparison
ADAM vs PRME Comparison
Compare ADAM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAM | PRME |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.9M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ADAM | PRME |
|---|---|---|
| Price | $7.29 | $3.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $7.50 | $6.42 |
| AVG Volume (30 Days) | 751.3K | ★ 3.8M |
| Earning Date | 02-18-2026 | 11-07-2025 |
| Dividend Yield | ★ 12.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $216,781,000.00 | $5,977,000.00 |
| Revenue This Year | $13.60 | $111.80 |
| Revenue Next Year | $49.42 | N/A |
| P/E Ratio | $37.63 | ★ N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $5.02 | $1.11 |
| 52 Week High | $7.75 | $6.94 |
Technical Indicators
Market Signals| Indicator | ADAM | PRME |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.04 |
| Support Level | N/A | $3.61 |
| Resistance Level | N/A | $4.12 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 1.38 |
Price Performance
Historical ComparisonAbout ADAM Adamas Trust Inc.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit sensitive single-family and multi-family assets.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.